Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Ranok Therapeutics
Ranok is a pre-clinical stage bio company pioneering targeted protein degradation technology.
Sector
Subsector
Keywords
Location
total rounds
total raised
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops innovative cancer therapeutics by modulating protein degradation pathways.
Sector
Subsector
Keywords
Location
total rounds
total raised
F5 Therapeutics
F5 Therapeutics is developing precision-based protein degradation to remove disease-causing proteins.
Sector
Subsector
Location
total rounds
Arvinas
Arvinas is a pharmaceutical company that develops novel therapeutics to treat a variety of diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 19.08.2024. Their latest round Post-IPO Equity
Biotechnology Value Fund
Biotechnology Value Fund is a venture capital firm in California that focuses on undervalued investments in the biotechnology sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors18
Number of lead investors
Number of investors
EcoR1 Capital
EcoR1 Capital is a biotech-focused investment advisory firm based in San Francisco.
Sector
Subsector
Location
count Of Investments
count Of Exists
Biotechnology Value Fund
Biotechnology Value Fund is a venture capital firm in California that focuses on undervalued investments in the biotechnology sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
T. Rowe Price
T. Rowe Price is an investment management firm that funds technology startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Nello Mainolfi
Nello is head of drug discovery at Raze Therapeutics. Before joining Raze, Nello spent almost a decade at the Novartis Institutes for Biomedical Research, where first as team member and then as interdisciplinary project team leader he contributed to the identification of more than 10 compounds that have entered preclinical and clinical development. While at Novartis he also championed new technologies such as using fragment-based drug discovery as a core strategy to deliver development candidates. Nello has authored multiple peer-reviewed publications; he is co-inventor on several patents and has written reviews in the areas of synthetic chemistry and drug discovery. Nello was trained at Imperial College, University of London and The Scripps Research Institute.
current job
organization founded
Nello Mainolfi
Nello Mainolfi
Nello Mainolfi is the Founder, President, and Chief Executive Officer at Kymera Therapeutics.
current job
organization founded
Nello Mainolfi
Employee Profiles11
Ellen Chiniara
Chief Legal Officer and Corporate Secretary
Vijay Sabesan
Senior Vice President, Technical Operations
Activity
Recent News9
The graph reveals the ratio (%) of positive news articles in a chosen time range